Eisai Co., Ltd. (TYO:4523)
4,638.00
+95.00 (2.09%)
Aug 15, 2025, 3:30 PM JST
Eisai Employees
Eisai had 10,917 employees as of March 31, 2025. The number of employees decreased by 150 or -1.36% compared to the previous year.
Employees
10,917
Change (1Y)
-150
Growth (1Y)
-1.36%
Revenue / Employee
73.56M JPY
Profits / Employee
4.61M JPY
Market Cap
1,307.39B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Mar 31, 2025 | 10,917 | -150 | -1.36% |
Mar 31, 2024 | 11,067 | -9 | -0.08% |
Mar 31, 2023 | 11,076 | -246 | -2.17% |
Mar 31, 2022 | 11,322 | 85 | 0.76% |
Mar 31, 2021 | 11,237 | 239 | 2.17% |
Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
Company Name | Employees |
---|---|
Chugai Pharmaceutical | 5,026 |
Takeda Pharmaceutical Company | 47,455 |
Daiichi Sankyo Company | 19,765 |
HOYA Corporation | 37,909 |
Otsuka Holdings | 35,338 |
Astellas Pharma | 13,643 |
Shionogi & | 4,955 |
Olympus | 29,297 |
Eisai News
- 8 days ago - Eli Lilly And Biogen (And Eisai): Muddying The Waters In Alzheimer's Disease - Seeking Alpha
- 10 days ago - Eisai Co., Ltd. 2026 Q1 - Results - Earnings Call Presentation - Seeking Alpha
- 10 days ago - Eisai Co., Ltd. (ESALF) Q1 2026 Earnings Call Transcript - Seeking Alpha
- 16 days ago - Eisai/Biogen, Eli Lilly highlight long-term data backing Alzheimer’s drugs - Seeking Alpha
- 17 days ago - Patients still benefit from Eisai and Biogen Alzheimer's drug after four years, study finds - Reuters
- 4 weeks ago - "URECE" (Dotinurad) Launched in China as a treatment for Gout - Benzinga
- 2 months ago - Eisai: Leqembi Approved In EU (Rating Downgrade) - Seeking Alpha
- 3 months ago - Eisai Co., Ltd. (ESALF) Q4 2025 Earnings Call Transcript - Seeking Alpha